Amazon Web Services (AWS) and venture capital company General Catalyst have partnered with the aim of strengthening healthcare ecosystems using generative artificial intelligence (genAI).

One of the partnership's key aims is to make healthcare more personalised. To meet this aim, Amazon Bedrock – Amazon’s machine learning platform for building genAI applications on AWS – will be used to develop genAI-based applications that help practitioners improve predictive analytics around patient treatment outcomes and gain insight into factors such as disease progression in fields such as radiology, pathology scanning, and genomic sequencing.

AWS CEO Matt Garman commented: "AWS and General Catalyst believe that AI has immense potential to effect meaningful change in global health care.

“Together, we are taking bold steps to improve patient outcomes and make quality care more accessible to all by embedding AI throughout the care journey."

General Catalyst said that the combination of its recently launched Health Assurance Transformation Company (HATCo), its portfolio of health tech companies and AWS, its offerings will now integrate with AWS's AI and data capabilities to enable health systems to deploy industry-specific cloud services to address critical unmet needs and to help personalise healthcare protocols.

General Catalyst CEO and managing director Hemant Taneja commented: “At General Catalyst, we've witnessed firsthand how technologies like AI, applied with the right approach to scaling and problem-solving, can drive real transformation in health care.

“AWS shares our bold vision for advancing human health through cutting-edge technology. Together, we believe this work will establish a flywheel of innovation and adoption that can be applied to other industries."

AWS’s collaboration with General Catalyst follows the extension of its partnership with Philips in November 2024. The Netherlands-based medtech giant stated that the collaboration aimed to unify diagnostic workflows, improve access to critical insights, and drive improved outcomes across clinical specialities with the power of genAI.

In other genAI in healthcare news, GE Healthcare revealed plans to launch CareIntellect this year, a genAI-based platform for breast and prostate cancer applications that can organise structured and unstructured data, including medical images, records, and notes.